Cancer drug prices are set to fall by up to 70% thanks to NPPA’s new trade margin caps.
Lilly Mounjaro Zepbound highlights the worst entry points in pharma approvals and their proven impact on the market.
Pharma revenue growth is projected at 11-13% as exports expand beyond the US.
Compass psychedelic drug launch is paving the way for new treatments in mental health.